Bellevue Life Sciences Acquisition Corp. Unit
BLACU
BLACU was delisted on the 14th of February, 2025.
23 hedge funds and large institutions have $29.6M invested in Bellevue Life Sciences Acquisition Corp. Unit in 2023 Q1 according to their latest regulatory filings, with 23 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
+$6.03M |
| 2 |
HIM
HGC Investment Management
Toronto,
Ontario, Canada
|
+$3.07M |
| 3 |
RCM
Rivernorth Capital Management
West Palm Beach,
Florida
|
+$2.56M |
| 4 |
SCM
Shaolin Capital Management
Miami,
Florida
|
+$2.56M |
| 5 |
ETH
Exos TFP Holdings
New York
|
+$2.05M |
Top Sellers
BLACU Hedge Fund Activity: Q1 2023 in Review
23 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in Bellevue Life Sciences Acquisition Corp. Unit (BLACU) for Q1 2023, worth a combined $29.6M.
Buyers outnumbered sellers: 23 funds opened new BLACU positions and 0 closed out — a net gain of 23 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Periscope Capital, opening a new position worth an estimated $6.03M.
- 23 institutional investors held Bellevue Life Sciences Acquisition Corp. Unit (BLACU) as of Q1 2023, up from 0 in Q4 2022.
- Funds reported $29.6M of Bellevue Life Sciences Acquisition Corp. Unit stock for Q1 2023.
- 23 funds opened new Bellevue Life Sciences Acquisition Corp. Unit positions in Q1 2023 and 0 closed out, a net change of +23 holders.
- The largest Bellevue Life Sciences Acquisition Corp. Unit buyer in Q1 2023 was Periscope Capital, an estimated $6.03M added.
Based on aggregated 13F filings for Q1 2023.